Celcuity (CELC) Selling, General & Administrative (2016 - 2025)

Celcuity (CELC) Selling, General & Administrative (2016 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -10.08 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 2.17 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 555.10 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 493.70 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 647.70 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 17.02 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -355.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 101.25 Mn
10 Celcuity 3.89 Bn 3.89 Bn - 11.57 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 11.57 Mn
Sep 30, 2025 7.93 Mn
Jun 30, 2025 3.79 Mn
Mar 31, 2025 3.91 Mn
Dec 31, 2024 2.96 Mn
Sep 30, 2024 2.47 Mn
Jun 30, 2024 1.79 Mn
Mar 31, 2024 1.85 Mn
Dec 31, 2023 1.65 Mn
Sep 30, 2023 1.41 Mn
Jun 30, 2023 1.31 Mn
Mar 31, 2023 1.27 Mn
Dec 31, 2022 1.04 Mn
Sep 30, 2022 1.02 Mn
Jun 30, 2022 1.23 Mn
Mar 31, 2022 811,292.00
Dec 31, 2021 829,851.00
Sep 30, 2021 639,271.00
Jun 30, 2021 573,360.00
Mar 31, 2021 555,428.00